At first-ever public hearing on CBD, advocates and FDA try to blaze trail to regulatory compromise

What happens when you put hemp farmers, moms against pot, and Ph.D. scientists in a room to discuss #CBD?
Candy made with cannabidiol, or CBD. Source: Jeremy Rehm/AP

SILVER SPRING, Md. — By 10:30 a.m., a panel of the Food and Drug Administration’s top regulators had already heard from more than 50 different people, all eager to squeeze their hopes or concerns about CBD, the booming marijuana-adjacent compound companies are suddenly adding to everything from dog food to dietary supplements, into the short speaking time they were granted.

There were mothers claiming marijuana drove their children to suicide, millennial entrepreneurs who struggled for a good answer

You're reading a preview, sign up to read more.

More from STAT

STAT6 min readSociety
Opinion: Covid-19 Testing: Overcoming Challenges In The Next Phase Of The Epidemic
Which is a better proxy for estimating the #Covid19 infection rate in the United States: the infection rate in the NBA or the infection rate in China or Italy?
STAT4 min read
We Shouldn’t Rush To Use An Unproven Malaria Drug To Treat The Coronavirus
No one know if this drug works. So doctors should avoid prescribing it, except perhaps to the most severely ill patients.
STAT4 min readSociety
Opinion: It’s Past Time To Fully Deploy The U.S. Public Health Service Commissioned Corps To Fight Covid-19
The U.S. Public Health Service Commissioned Corps is the world's only national uniformed service devoted to protecting, promoting, and advancing the health and safety of a nation. Put it to…